Riikka Huovinen

- Docent,
Faculty of Medicine (University of Turku)

riikka.huovinen@utu.fi

Publications

3 of 4

Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients (2020)
- Osteoporosis International
L. Vehmanen, H. Sievänen, P. Kellokumpu-Lehtinen, R. Nikander, R. Huovinen, J. Ruohola, H.M. Penttinen, M. Utriainen, K. Tokola, C. Blomqvist, T. Saarto
(A1 Refereed original research article in a scientific journal)
Granulocyte colony-stimulating factor- and chemotherapy-induced large-vessel vasculitis: six patient cases and a systematic literature review (2020)
- Rheumatology Advances in Practice
Kirsi Taimen, Samu Heino, Ia Kohonen, Heikki Relas, Riikka Huovinen, Arno Hänninen, Laura Pirilä
(A2 Refereed review article in a scientific journal )
Health-related Quality of Life of Breast Cancer Survivors Attending an Exercise Intervention Study: A Five-year Follow-up (2020)
- In Vivo
Roine E, Sintonen H, Kellokumpu-Lehtinen PL, Penttinen H, Utriainen M, Vehmanen L, Huovinen R, Kautiainen H, Nikander R, Blomqvist C, Saarto T
(A1 Refereed original research article in a scientific journal)
CHEMOTHERAPY AND G-CSF INDUCED LARGE VESSEL VASCULITIS AND CAROTIDYNIA - SIX PATIENT CASES AND A SYSTEMATIC LITERATURE REVIEW (2019)
- Annals of the Rheumatic Diseases
Taimen K, Heino S, Kohonen I, Relas H, Huovinen R, Hanninen A, Pirila L
(Other publication)
Effectiveness of a 12-month Exercise Intervention on Physical Activity and Quality of Life of Breast Cancer Survivors; Five-year Results of the BREX-study (2019)
- In Vivo
Vehmanen L., Huovinen R., Saarto T., Penttinen H., Utriainen M., Kellokumpu-Lehtinen P., Raitanen J., Sievänen H., Nikander R., Blomqvist C.
(A1 Refereed original research article in a scientific journal)
Potilaan ikä ja syövän levinneisyys vaikuttavat rintasyövän hoitokustannuksiin (2019)
- Duodecim
Lehtinen M, Heinävaara S, Sarkeala T, Karlsson A, Tukiainen M, Huovinen R, Anttila A
(A1 Refereed original research article in a scientific journal)
Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer The SOLD Randomized Clinical Trial (2018)
- JAMA Oncology
Joensuu H, Fraser J, Wildiers H, Huovinen R, Auvinen P, Utriainen M, Nyandoto P, Villman KK, Halonen P, Granstam-Bjorneklett H, Lundgren L, Sailas L, Turpeenniemi-Hujanen T, Tanner M, Yachnin J, Ritchie D, Johansson O, Huttunen T, Neven P, Canney P, Harvey VJ, Kellokumpu-Lehtinen PL, Lindman H
(A1 Refereed original research article in a scientific journal)
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years (2017)
- New England Journal of Medicine
Pan HC, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, Hayes DF; for the EBCTCG
(A1 Refereed original research article in a scientific journal)
Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer The Randomized Clinical FinXX Trial (2017)
- JAMA Oncology
Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola-Vuorinen A, Tanner M, Kokko R, Ahlgren J, Auvinen P, Lahdenpera O, Kosonen S, Villman K, Nyandoto P, Nilsson G, Poikonen-Saksela P, Kataja V, Junnila J, Bono P, Lindman H
(A1 Refereed original research article in a scientific journal)
Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors (2017)
- British Journal of Cancer
Uusitalo E, Kallionpää RA, Kurki S, Rantanen M, Pitkäniemi J, Kronqvist P, Härkönen P, Huovinen R, Carpen O, Pöyhönen M, Peltonen S, Peltonen J.
(A1 Refereed original research article in a scientific journal)